The AMPK/PPAR-γ/PGC-1α signalling pathway is involved in the anti-obesity effects of adiponectin (57, 58), while both adiponectin (34, 59–61) and physical exercise (34, 36) activate the AMPK signalling pathway. Here, PPARG is linked to obesity disorder.